Celcuity (CELC)
(Delayed Data from NSDQ)
$13.98 USD
-0.87 (-5.86%)
Updated Sep 23, 2024 04:00 PM ET
After-Market: $13.94 -0.04 (-0.29%) 5:14 PM ET
2-Buy of 5 2
D Value D Growth B Momentum D VGM
Income Statements
Fiscal Year end for Celcuity, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 0 | 0 | 0 | 0 | 0 |
Cost Of Goods | 0 | 0 | 0 | 0 | 0 |
Gross Profit | 0 | 0 | 0 | 0 | 0 |
Selling & Adminstrative & Depr. & Amort Expenses | 66 | 39 | 28 | 10 | 8 |
Income After Depreciation & Amortization | -66 | -39 | -28 | -10 | -8 |
Non-Operating Income | 8 | 1 | 0 | 0 | 0 |
Interest Expense | 5 | 2 | 1 | 0 | 0 |
Pretax Income | -64 | -40 | -30 | -9 | -7 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -64 | -40 | -30 | -9 | -7 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -64 | -40 | -30 | -9 | -7 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -66 | -39 | -28 | -9 | -7 |
Depreciation & Amortization (Cash Flow) | 0 | 1 | 1 | 0 | 0 |
Income After Depreciation & Amortization | -66 | -39 | -28 | -10 | -8 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 23.68 | 15.42 | 13.38 | 10.27 | 10.23 |
Diluted EPS Before Non-Recurring Items | -2.69 | -2.64 | -2.21 | -0.92 | -0.72 |
Diluted Net EPS (GAAP) | -2.69 | -2.64 | -2.21 | -0.92 | -0.72 |
Fiscal Year end for Celcuity, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cost Of Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A, R&D, and Dept/Amort Expenses | 24.29 | 22.50 | 19.73 | 18.90 | 15.06 |
Income After SG&A, R&D, and Dept/Amort Expenses | -24.29 | -22.50 | -19.73 | -18.90 | -15.06 |
Non-Operating Income | 2.82 | 2.28 | 2.28 | 1.87 | 1.78 |
Interest Expense | 2.26 | 1.40 | 1.40 | 1.37 | 1.31 |
Pretax Income | -23.72 | -21.61 | -18.85 | -18.40 | -14.59 |
Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -23.72 | -21.61 | -18.85 | -18.40 | -14.59 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -23.72 | -21.61 | -18.85 | -18.40 | -14.59 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 38.44 | 33.61 | 28.90 | 22.12 | 21.96 |
Diluted EPS Before Non-Recurring Items | -0.62 | -0.64 | -0.65 | -0.83 | -0.66 |
Diluted Net EPS (GAAP) | -0.62 | -0.64 | -0.65 | -0.83 | -0.66 |